Cargando…

Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign

BACKGROUND: In April 2014, a national school-based human papillomavirus (HPV) vaccination program was rolled out in South Africa, targeting Grade 4 girls aged ≥9 years. A bivalent HPV vaccine with a 2-dose (6 months apart) schedule was used. At the request of the National Department of Health (NDoH)...

Descripción completa

Detalles Bibliográficos
Autores principales: Delany-Moretlwe, Sinead, Kelley, Karen F., James, Shamagonam, Scorgie, Fiona, Subedar, Hasina, Dlamini, Nonhlanhla R, Pillay, Yogan, Naidoo, Nicolette, Chikandiwa, Admire, Rees, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Global Health: Science and Practice 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172125/
https://www.ncbi.nlm.nih.gov/pubmed/30143561
http://dx.doi.org/10.9745/GHSP-D-18-00090
_version_ 1783360881277534208
author Delany-Moretlwe, Sinead
Kelley, Karen F.
James, Shamagonam
Scorgie, Fiona
Subedar, Hasina
Dlamini, Nonhlanhla R
Pillay, Yogan
Naidoo, Nicolette
Chikandiwa, Admire
Rees, Helen
author_facet Delany-Moretlwe, Sinead
Kelley, Karen F.
James, Shamagonam
Scorgie, Fiona
Subedar, Hasina
Dlamini, Nonhlanhla R
Pillay, Yogan
Naidoo, Nicolette
Chikandiwa, Admire
Rees, Helen
author_sort Delany-Moretlwe, Sinead
collection PubMed
description BACKGROUND: In April 2014, a national school-based human papillomavirus (HPV) vaccination program was rolled out in South Africa, targeting Grade 4 girls aged ≥9 years. A bivalent HPV vaccine with a 2-dose (6 months apart) schedule was used. At the request of the National Department of Health (NDoH), we conducted an external assessment of the first-dose phase of the vaccination program to evaluate program coverage and vaccine safety and identify factors that influenced implementation. METHODS: We based our cross-sectional and mixed-methods approach on a process evaluation framework, which included a review of key planning and implementation documents and monitoring data; observation at vaccination sites; key informant interviews (N=34); and an assessment of media coverage and content related to the campaign. Findings: There was overall success in key measures of coverage and safety. Over 350,000 Grade 4 girls were vaccinated in more than 16,000 public schools across South Africa, which translated to 94.6% of schools reached and 86.6% of age-eligible learners vaccinated. No major adverse events following immunization were detected. We attributed the campaign's successes to careful planning and coordination and strong leadership from the NDoH. The primary challenges we identified were related to obtaining informed consent, vulnerabilities in cold chain capacity, and onsite management of minor adverse events. While campaign planners anticipated and prepared for some negative media coverage, they did not expect the use of social media for spreading misinformation about HPV vaccination. CONCLUSIONS: The first phase of the national school-based HPV vaccination campaign was successfully implemented at scale in this setting. Future implementation will require improvement in the storage and monitoring of vaccine doses, better communication of role expectations to all stakeholders, and streamlined consent processes to ensure program sustainability.
format Online
Article
Text
id pubmed-6172125
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Global Health: Science and Practice
record_format MEDLINE/PubMed
spelling pubmed-61721252018-10-21 Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign Delany-Moretlwe, Sinead Kelley, Karen F. James, Shamagonam Scorgie, Fiona Subedar, Hasina Dlamini, Nonhlanhla R Pillay, Yogan Naidoo, Nicolette Chikandiwa, Admire Rees, Helen Glob Health Sci Pract Original Articles BACKGROUND: In April 2014, a national school-based human papillomavirus (HPV) vaccination program was rolled out in South Africa, targeting Grade 4 girls aged ≥9 years. A bivalent HPV vaccine with a 2-dose (6 months apart) schedule was used. At the request of the National Department of Health (NDoH), we conducted an external assessment of the first-dose phase of the vaccination program to evaluate program coverage and vaccine safety and identify factors that influenced implementation. METHODS: We based our cross-sectional and mixed-methods approach on a process evaluation framework, which included a review of key planning and implementation documents and monitoring data; observation at vaccination sites; key informant interviews (N=34); and an assessment of media coverage and content related to the campaign. Findings: There was overall success in key measures of coverage and safety. Over 350,000 Grade 4 girls were vaccinated in more than 16,000 public schools across South Africa, which translated to 94.6% of schools reached and 86.6% of age-eligible learners vaccinated. No major adverse events following immunization were detected. We attributed the campaign's successes to careful planning and coordination and strong leadership from the NDoH. The primary challenges we identified were related to obtaining informed consent, vulnerabilities in cold chain capacity, and onsite management of minor adverse events. While campaign planners anticipated and prepared for some negative media coverage, they did not expect the use of social media for spreading misinformation about HPV vaccination. CONCLUSIONS: The first phase of the national school-based HPV vaccination campaign was successfully implemented at scale in this setting. Future implementation will require improvement in the storage and monitoring of vaccine doses, better communication of role expectations to all stakeholders, and streamlined consent processes to ensure program sustainability. Global Health: Science and Practice 2018-10-03 /pmc/articles/PMC6172125/ /pubmed/30143561 http://dx.doi.org/10.9745/GHSP-D-18-00090 Text en © Delany-Moretlwe et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited. To view a copy of the license, visit http://creativecommons.org/licenses/by/4.0/. When linking to this article, please use the following permanent link: https://doi.org/10.9745/GHSP-D-18-00090
spellingShingle Original Articles
Delany-Moretlwe, Sinead
Kelley, Karen F.
James, Shamagonam
Scorgie, Fiona
Subedar, Hasina
Dlamini, Nonhlanhla R
Pillay, Yogan
Naidoo, Nicolette
Chikandiwa, Admire
Rees, Helen
Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign
title Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign
title_full Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign
title_fullStr Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign
title_full_unstemmed Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign
title_short Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign
title_sort human papillomavirus vaccine introduction in south africa: implementation lessons from an evaluation of the national school-based vaccination campaign
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172125/
https://www.ncbi.nlm.nih.gov/pubmed/30143561
http://dx.doi.org/10.9745/GHSP-D-18-00090
work_keys_str_mv AT delanymoretlwesinead humanpapillomavirusvaccineintroductioninsouthafricaimplementationlessonsfromanevaluationofthenationalschoolbasedvaccinationcampaign
AT kelleykarenf humanpapillomavirusvaccineintroductioninsouthafricaimplementationlessonsfromanevaluationofthenationalschoolbasedvaccinationcampaign
AT jamesshamagonam humanpapillomavirusvaccineintroductioninsouthafricaimplementationlessonsfromanevaluationofthenationalschoolbasedvaccinationcampaign
AT scorgiefiona humanpapillomavirusvaccineintroductioninsouthafricaimplementationlessonsfromanevaluationofthenationalschoolbasedvaccinationcampaign
AT subedarhasina humanpapillomavirusvaccineintroductioninsouthafricaimplementationlessonsfromanevaluationofthenationalschoolbasedvaccinationcampaign
AT dlamininonhlanhlar humanpapillomavirusvaccineintroductioninsouthafricaimplementationlessonsfromanevaluationofthenationalschoolbasedvaccinationcampaign
AT pillayyogan humanpapillomavirusvaccineintroductioninsouthafricaimplementationlessonsfromanevaluationofthenationalschoolbasedvaccinationcampaign
AT naidoonicolette humanpapillomavirusvaccineintroductioninsouthafricaimplementationlessonsfromanevaluationofthenationalschoolbasedvaccinationcampaign
AT chikandiwaadmire humanpapillomavirusvaccineintroductioninsouthafricaimplementationlessonsfromanevaluationofthenationalschoolbasedvaccinationcampaign
AT reeshelen humanpapillomavirusvaccineintroductioninsouthafricaimplementationlessonsfromanevaluationofthenationalschoolbasedvaccinationcampaign